Laserfiche WebLink
Exhibit A <br />OPIOI D ABATEMENT STRATEGIES <br />Participating Local Governments that receive a direct payment maintain full <br />discretion over the use and distribution of their allocation of Opioid Funds, <br />provided the Opioid Funds are used solely for Approved purposes. Reasonable <br />administrative costs for a Participating Local Government to administer its <br />aflocation of Opioid Funds shall not exceed actual costs or LO% of the <br />Participating Local Government's allocation Opioid Funds, whichever is tess. <br />PART ONE: TREATMENT <br />A. TREAT OPIOI D USE DISORDER (OU D <br />Support treatment of Opioid Use Disorder (OUD) and any co-occurring Substance Use <br />Disorder or Mental Health (SUD/MH) conditions. Co-usage, and/or co-addiction through <br />evidence-based, evidence-informed, or promising programs or strategies that may include, <br />but are not limited to, the following: <br />L. Expand availability of treatment for OUD and any co-occurring SUD/MH conditions, <br />co-usage, and/or co-addiction. lncluding all forms of Medication-Assisted Treatment <br />(MAT) approved by the U.S. Food and Drug Administration. <br />2' Support and reimburse services that include the full American Society of Addiction <br />Medicine (ASAM) continuum of care for OUD and any co-occurring SUD/MH <br />conditions, co-usage, and/or co-addiction, including but not limited to: <br />Medication-Assisted Treatment (MAT); <br />Abstinence-based treatment; <br />c. Treatment, recovery, or other services provided by states, subdivisions, <br />community health centers; non-for-profit providers; or for-profit providers; <br />d' Treatment by providers that focus on OUD treatment as well as treatment by <br />providers that offer OUD treatment along with treatment for other SUD/MH <br />condition, co-usage, and/or co-addiction; or <br />a <br />b